IR vs RCKTW
Ingersoll Rand Inc (IR) versus Rocket Pharmaceuticals, Inc. Warrant (RCKTW) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Rocket Pharmaceuticals, Inc. Warrant (RCKTW) is a biotechnology company listed on US.
Latest reported IR revenue for 2025-12-31 was $7.65B. Net income was $581.4M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
RCKTW does not have a complete income-statement cache yet.
IR currently screens at market cap $28.27B and trailing P/E 48.8. RCKTW currently screens at market cap $0.
Not investment advice. Open the IR and RCKTW stock pages for the full models.
Not investment advice.